FDA increasing efforts to support CTGT product development | Hogan Lovells

FDA has recently increased its efforts to support the development and approval of cell, tissue, and gene therapy (CTGT) products. This is evidenced by the upswing in CTGT approvals in...

Related Keywords

Nicole Verdun ,Office Of Therapeutic Products ,Platform Technology Designation ,Drug Law Institute ,Platform Technology Designation Programs ,Trials Advancing Rare ,Consensus Standards ,Century Cures Act ,Technology Designation ,Therapeutic Products ,Split Real Time Application Review ,Rare Disease Endpoint Advancement ,